How to buy Twist Bioscience Corporation stock

Twist Bioscience Corporation is a diagnostics & research business based in the US. Twist Bioscience Corporation shares (TWST) are listed on the NASDAQ and all prices are listed in US Dollars. Twist Bioscience Corporation employs 525 staff and has a trailing 12-month revenue of around 0.00.

Twist Bioscience Corporation share price

Use our graph to track the performance of TWST stocks over time.

Twist Bioscience Corporation shares at a glance

• Key figures

Information last updated 2021-04-23.

52-week range	$29.56 - $214.07
50-day moving average	$128.56
200-day moving average	$131.81
Wall St. target price	$146.00
PE ratio	N/A
Dividend yield	N/A (0%)
Earnings per share (TTM)	$-4.79

Buy Twist Bioscience Corporation shares from these brokerages

Compare special offers, low fees and a wide range of types of investments among top trading platforms.

*Signup bonus information updated weekly.

Is it a good time to buy Twist Bioscience Corporation stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

Technical Analysis of Twist Bioscience Corporation by TradingView

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Twist Bioscience Corporation financials

Revenue TTM	$101.1 million
Gross profit TTM	$28.7 million
Return on assets TTM	-16.4%
Return on equity TTM	-31.63%
Profit margin	-115.92%
Book value	$13.12
Market capitalisation	$6.5 billion

TTM: trailing 12 months

Shorting Twist Bioscience Corporation shares

There are currently 4.1 million Twist Bioscience Corporation shares held short by investors – that's known as Twist Bioscience Corporation's "short interest". This figure is 14.3% up from 3.6 million last month.

There are a few different ways that this level of interest in shorting Twist Bioscience Corporation shares can be evaluated.

Twist Bioscience Corporation's "short interest ratio" (SIR)

Twist Bioscience Corporation's "short interest ratio" (SIR) is the quantity of Twist Bioscience Corporation shares currently shorted divided by the average quantity of Twist Bioscience Corporation shares traded daily (recently around 1.2 million). Twist Bioscience Corporation's SIR currently stands at 3.31. In other words for every 100,000 Twist Bioscience Corporation shares traded daily on the market, roughly 3310 shares are currently held short.

However Twist Bioscience Corporation's short interest can also be evaluated against the total number of Twist Bioscience Corporation shares, or, against the total number of tradable Twist Bioscience Corporation shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Twist Bioscience Corporation's short interest could be expressed as 0.08% of the outstanding shares (for every 100,000 Twist Bioscience Corporation shares in existence, roughly 80 shares are currently held short) or 0.0879% of the tradable shares (for every 100,000 tradable Twist Bioscience Corporation shares, roughly 88 shares are currently held short).

Such a low SIR usually points to an optimistic outlook for the share price, with fewer people currently willing to bet against Twist Bioscience Corporation.

Find out more about how you can short Twist Bioscience Corporation stock.

Twist Bioscience Corporation share dividends

We're not expecting Twist Bioscience Corporation to pay a dividend over the next 12 months.

Twist Bioscience Corporation share price volatility

Over the last 12 months, Twist Bioscience Corporation's shares have ranged in value from as little as $29.56 up to $214.07. A popular way to gauge a stock's volatility is its "beta".

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Twist Bioscience Corporation's is 0.6958. This would suggest that Twist Bioscience Corporation's shares are less volatile than average (for this exchange).

Twist Bioscience Corporation overview

Twist Bioscience Corporation, a synthetic biology company, manufactures and sells synthetic DNA-based products. The company's DNA synthesis platform enables the manufacturing of synthetic DNA by writing DNA on a silicon chip. It offers synthetic DNA-based products, including synthetic genes, tools for sample preparation, antibody libraries for drug discovery and development, and DNA as a digital data storage medium. The company has a collaboration agreements with ImmunoPrecise Antibodies Ltd. ; Victorian Clinical Genetic Services; and Kyowa Kirin Pharmaceutical Research, Inc. Twist Bioscience Corporation was founded in 2013 and is headquartered in South San Francisco, California. .

Frequently asked questions

• What percentage of Twist Bioscience Corporation is owned by insiders or institutions?

  Currently 9.461% of Twist Bioscience Corporation shares are held by insiders and 95.148% by institutions.

• How many people work for Twist Bioscience Corporation?

  Latest data suggests 525 work at Twist Bioscience Corporation.

• When does the fiscal year end for Twist Bioscience Corporation?

  Twist Bioscience Corporation's fiscal year ends in September.

• Where is Twist Bioscience Corporation based?

  Twist Bioscience Corporation's address is: 681 Gateway Boulevard, South San Francisco, CA, United States, 94080

• What is Twist Bioscience Corporation's ISIN number?

  Twist Bioscience Corporation's international securities identification number is: US90184D1000

• What is Twist Bioscience Corporation's CUSIP number?

  Twist Bioscience Corporation's Committee on Uniform Securities Identification Procedures number is: 90184D100